Literature DB >> 11467797

Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9).

T L Lamagni1, B G Evans, M Shigematsu, E M Johnson.   

Abstract

Invasive fungal infections are becoming an increasing public health problem owing to the growth in numbers of susceptible individuals. Despite this, the profile of mycoses remains low and there is no surveillance system specific to fungal infections currently existing in England and Wales. We analysed laboratory reports of deep-seated mycoses made to the Communicable Disease Surveillance Centre between 1990 and 1999 from England and Wales. A substantial rise in candidosis was seen during this period (6.76-13.70 reports per million population/year), particularly in the older age groups. Rates of cryptococcosis in males fluctuated over the decade but fell overall (1.05-0.66 per million population/year), whereas rates of female cases gradually rose up until 1998 (0.04-0.41 per million population/year). Reports of Pneumocystis carinii in men reduced substantially between 1990 and 1999 (2.77-0.42 per million population/year) but showed little change in women. Reports of aspergillosis fluctuated up until 1996, after which reports of male and female cases rose substantially (from 0.08 for both in 1996 to 1.92 and 1.69 per million population/year in 1999 for males and females respectively), largely accounted for by changes in reporting practice from one laboratory. Rates of invasive mycoses were generally higher in males than females, with overall male-to-female rate ratios of 1.32 (95% CI 1.25-1.40) for candidosis, 1.30 (95% CI 1.05-1.60) for aspergillosis, 3.99 (95% CI 2.93-5.53) for cryptococcosis and 4.36 (95% CI 3.47-5.53) for Pneumocystis carinii. The higher male than female rates of reports is likely to be a partial reflection of HIV epidemiology in England and Wales, although this does not fully explain the ratio in infants and older age groups. Lack of information on underlying predisposition prevents further identification of risk groups affected. Whilst substantial under-reporting of Pneumocystis carinii and Cryptococcus species was apparent, considerable numbers of superficial mycoses were misreported indicating a need for clarification of reporting guidelines. Efforts to enhance comprehensive laboratory reporting should be undertaken to maximize the utility of this approach for surveillance of deep-seated fungal infections.

Entities:  

Mesh:

Year:  2001        PMID: 11467797      PMCID: PMC2869708          DOI: 10.1017/s0950268801005507

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  32 in total

1.  Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

2.  Fructose-1,6-bisphosphate reduces the mortality in Candida albicans bloodstream infection and prevents the septic-induced platelet decrease.

Authors:  Roberto Christ Vianna Santos; Rafael Noal Moresco; Miguel Angel Peña Rico; Antonio R García Susperregui; Jose Luis Rosa; Ramon Bartrons; Francesc Ventura; Débora Nunes Mário; Sydney Hartz Alves; Etiane Tatsch; Helena Kober; Ricardo Obalski de Mello; Patrícia Scherer; Henrique Bregolin Dias; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

3.  Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience.

Authors:  Nihal Özdemir; Gülen Tüysüz; Nigar Çelik; Leman Yantri; Ethem Erginöz; Hilmi Apak; Alp Özkan; İnci Yıldız; Tiraje Celkan
Journal:  Turk Pediatri Ars       Date:  2016-06-01

4.  Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model.

Authors:  Read Pukkila-Worley; Anton Y Peleg; Emmanouil Tampakakis; Eleftherios Mylonakis
Journal:  Eukaryot Cell       Date:  2009-08-07

5.  Contact-free inactivation of Candida albicans biofilms by cold atmospheric air plasma.

Authors:  Tim Maisch; Tetsuji Shimizu; Georg Isbary; Julia Heinlin; Sigrid Karrer; Tobias G Klämpfl; Yang-Fang Li; Gregor Morfill; Julia L Zimmermann
Journal:  Appl Environ Microbiol       Date:  2012-03-30       Impact factor: 4.792

6.  Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both.

Authors:  Fanny Lanternier; Seyed Alireza Mahdaviani; Elisa Barbati; Hélène Chaussade; Yatrika Koumar; Romain Levy; Blandine Denis; Anne-Sophie Brunel; Sophie Martin; Michèle Loop; Julie Peeters; Ariel de Selys; Jean Vanclaire; Christiane Vermylen; Marie-Cécile Nassogne; Olga Chatzis; Luyan Liu; Mélanie Migaud; Vincent Pedergnana; Guillaume Desoubeaux; Gregory Jouvion; Fabrice Chretien; Ilad Alavi Darazam; Alejandro A Schäffer; Mihai G Netea; Jean J De Bruycker; Louis Bernard; Jacques Reynes; Noureddine Amazrine; Laurent Abel; Dimitri Van der Linden; Tom Harrison; Capucine Picard; Olivier Lortholary; Davood Mansouri; Jean-Laurent Casanova; Anne Puel
Journal:  J Allergy Clin Immunol       Date:  2015-02-19       Impact factor: 10.793

7.  Ras pathway signaling accelerates programmed cell death in the pathogenic fungus Candida albicans.

Authors:  Andrew J Phillips; Jonathan D Crowe; Mark Ramsdale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-10       Impact factor: 11.205

8.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.

Authors:  C A Enwuru; A Ogunledun; N Idika; N V Enwuru; F Ogbonna; M Aniedobe; A Adeiga
Journal:  Afr Health Sci       Date:  2008-09       Impact factor: 0.927

10.  Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.

Authors:  Mohammed S Ahmadi; Hiu Ham Lee; David A Sanchez; Adam J Friedman; Moses T Tar; Kelvin P Davies; Joshua D Nosanchuk; Luis R Martinez
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.